Scynexis Profit Margin

The latest profit margin for SCYX is -122.52% as of March 2026. That compares with -1141.59% in the prior-year period — up 89.3% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Scynexis's historical trend and sector peers before judging valuation or financial health.

Over the past year, SCYX's profit margin moved from -1141.59% to -122.52% — a 89.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Scynexis's valuation or profitability profile.

Against Healthcare companies, SCYX currently prints -122.52% for profit margin, while the sector average sits near 14.34%. That is roughly 954.1% below the sector mean. Large gaps often invite a closer look at Scynexis's growth, margins, and balance sheet.

Profit Margin shows how effectively Scynexis converts resources into returns. At -122.52%, SCYX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1141.59% in the prior-year period — up 89.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SCYX's profit margin (-122.52%), review year-over-year change from -1141.59%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.